Methotrexate and MX-68, a new derivative of methotrexate, limit infarct size via adenosine-dependent mechanisms in canine hearts.

Hiroshi Asanuma; Shoji Sanada; Akiko Ogai; Tetsuo Minamino; Seiji Takashima; Masanori Asakura; Hisakazu Ogita; Yoshiro Shinozaki; Hidezo Mori; Koichi Node

doi:10.1097/00005344-200404000-00013

Methotrexate and MX-68, a new derivative of methotrexate, limit infarct size via adenosine-dependent mechanisms in canine hearts.

Identifier:nobleid.org/w1/20260515/3FEFD3B0

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/3FEFD3B0.svg?ark=w1%2F20260515%2F3FEFD3B0)](https://nobleid.org/work/w1/20260515/3FEFD3B0)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Methotrexate and MX-68, a new derivative of methotrexate, limit infarct size via adenosine-dependent mechanisms in canine hearts.

Identifier:nobleid.org/w1/20260515/3FEFD3B0

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/3FEFD3B0.svg?ark=w1%2F20260515%2F3FEFD3B0)](https://nobleid.org/work/w1/20260515/3FEFD3B0)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work